The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic [4]

Archives of Neurology

Volumn 60, Issue 8, 2003, Pages 1170-1173

  Horstink, Martin W I M ^a   Van Engelen, Baziel G ^a   Shults, Clifford W ^a   Haas, Richard ^a   Oakes, David ^a   Kieburtz, Karl ^a   Plumb, Sandra ^a   Shoulson, Ira ^a   Kurlan, Roger ^a   Beal, M Flint ^a   Juncos, Jorge ^a   Watts, Ray ^a   Nutt, John ^a   Carter, Julie ^a   Kompoliti, Katie ^a   Perlmutter, Joel ^a   Reich, Stephen ^a   Stern, Matt ^a   Molho, Eric ^a   Harrison, Madeline ^a   Lew, Mark ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DECARBOXYLASE INHIBITOR; LEVODOPA; PERGOLIDE; SELEGILINE; UBIDECARENONE; ALPHA TOCOPHEROL; ANTIOXIDANT; DRUG DERIVATIVE; UBIQUINONE;

BRAIN NERVE CELL; CELL DEATH; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; IDIOPATHIC DISEASE; LABORATORY TEST; LETTER; MULTIVARIATE ANALYSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; AGED; ANIMAL; BLOOD; DISEASE COURSE; DRUG INTERACTION; MIDDLE AGED; NOTE; RAT;

AGED; ANIMALS; ANTIOXIDANTS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; MIDDLE AGED; PARKINSON DISEASE; RATS; TREATMENT OUTCOME; UBIQUINONE; VITAMIN E;

EID: 0041783516     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.8.1170-b     Document Type: Letter

References (0)